https://scholars.lib.ntu.edu.tw/handle/123456789/387953
標題: | Primary treatment and prognostic factors of carcinosarcoma of the ovary, fallopian tube, and peritoneum: A Taiwanese Gynecologic Oncology Group study | 作者: | I-HUI CHEN | 關鍵字: | Carcinosarcoma; Malignant mixed M?llerian tumor; Ovarian cancer | 公開日期: | 2014 | 卷: | 24 | 期: | 3 | 起(迄)頁: | 506-512 | 來源出版物: | International Journal of Gynecological Cancer | 摘要: | Objective: This study aimed to determine the clinical prognostic factors involved in carcinosarcoma of the ovary, fallopian tube, and peritoneum. Materials and Methods: This retrospective study was undertaken by the Taiwanese Gynecologic Oncology Group. The retrieved clinical data included demographic characteristics, medical disease, tumor status, extent of surgery, and adjuvant chemotherapy. Results: In total, 63 patients with carcinosarcoma of the ovary, fallopian tube, and peritoneum were identified. Sixty-one patients with complete datawere enrolled for further data analysis. The mean follow-up period was 1.0 year, and the mean overall survival was 15.4 months. By log-rank tests, age, menopausal status, parity, hypertension, diabetes, primary tumor size, para-aortic lymph node metastasis, pretreatment CA-125, preceding diagnostic surgery, hysterectomy, lymphadenectomy, other surgeries, and paclitaxel use were not predictive of overall survival. Omentectomy, no gross residual implants after surgery, platinum treatment, and no pelvic lymph node metastasis had a trend toward better survival. Early diagnosis at stage I and cisplatin/ifosfamide regimen were significant associated with a better overall survival in logrank and simple Cox regression tests. Bilateral ovarian tumors and metastatic tumors larger than 2 cm were significantly associated with a poorer overall survival. Conclusions: Early diagnosis at stage I, unilateral ovarian tumor, metastatic tumors less than 2 cm, and cisplatin/ifosfamide regimen were predictive of a better survival. Omentectomy and complete debulking surgery also showed a trend toward better survival. Thus, these treatment strategies should be applied in patients with carcinosarcoma of the ovary, fallopian tube, and peritoneum. Ifosfamide, Paclitaxel, Debulking operation Copyright ? 2014 by IGCS and ESGO. |
URI: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84900402079&partnerID=MN8TOARS http://scholars.lib.ntu.edu.tw/handle/123456789/387953 |
DOI: | 10.1097/IGC.0000000000000083 | SDG/關鍵字: | CA 125 antigen; carboplatin; cisplatin; ifosfamide; paclitaxel; adult; age; aged; article; cancer adjuvant therapy; cancer combination chemotherapy; cancer prognosis; cancer size; cancer staging; cancer surgery; cancer survival; carcinosarcoma; demography; diabetes mellitus; early diagnosis; female; follow up; human; hypertension; hysterectomy; laparoscopic surgery; laparotomy; lymph node dissection; lymph node metastasis; major clinical study; menopause; omentectomy; ovariectomy; ovary carcinoma; overall survival; paraaortic lymph node; parity; pelvis lymph node; pelvis lymphadenectomy; peritoneum cancer; primary tumor; priority journal; retrospective study; salpingooophorectomy; survival prediction; uterine tube carcinoma; adolescent; carcinosarcoma; clinical trial; epidemiology; Fallopian Tube Neoplasms; middle aged; mortality; multicenter study; Ovarian Neoplasms; Peritoneal Neoplasms; prognosis; Taiwan; very elderly; young adult; Adolescent; Adult; Aged; Aged, 80 and over; Carcinosarcoma; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Taiwan; Young Adult |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。